Positron Emission Tomography in Breast Cancer

Positron Emission Tomography in Breast Cancer

Gradually, FDG-PET/CT has been strengthening within the diagnostic algorithms of oncological diseases. In many of these, PET/CT has shown to be useful at different stages of the disease: diagnosis, staging or re-staging, treatment response assessment, and recurrence. Some of the advantages of this i...

Full description

Bibliographic Details
Main Authors:	Jose Luis Vercher-Conejero, Laura Pelegrí-Martinez, Diego Lopez-Aznar, María del Puig Cózar-Santiago
Format:	Article
Language:	English
Published:	MDPI AG 2015-03-01
Series:	Diagnostics
Subjects:	FDG-PET PET/CT PET/MRI breast cancer dedicated breast PET non-FDG radiopharmaceuticals
Online Access:	http://www.mdpi.com/2075-4418/5/1/61

Similar Items

The Role of Positron Emission Tomography- Computed Tomography/Magnetic Resonance Imaging in Modern Medicine
by: Sina Houshmand, et al.
Published: (2014-09-01)

Current Role and Future Prospects of Positron Emission Tomography (PET)/Computed Tomography (CT) in the Management of Breast Cancer
by: Nicole Robson, et al.
Published: (2024-02-01)

Innovations in Positron Emission Tomography and State of the Art in the Evaluation of Breast Cancer Treatment Response
by: Luigi Castorina, et al.
Published: (2023-12-01)

Characterization and Pilot Human Trial of Dedicated Breast Ring Positron Emission Tomography (BRPET) System
by: Andrew M. Polemi, et al.
Published: (2021-09-01)

Fluorodeoxyglucose positron emission tomography/computed tomography findings in a patient with cerebellar mutism after operation in posterior fossa
by: Gonca Kara Gedik, et al.
Published: (2017-03-01)

Positron Emission Tomography (PET) in Oncology
by: Andrea Gallamini, et al.
Published: (2014-09-01)

Diagnostic accuracy of fluorine-18 fluorodeoxyglucose positron emission tomography for suspected primary and postoperative pyogenic spondylitis
by: Qingyu Zhang, et al.
Published: (2023-01-01)

Comparison of diagnostic sensitivity of [18F]fluoroestradiol and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for breast cancer recurrence in patients with a history of estrogen receptor-positive primary breast cancer
by: Sun Young Chae, et al.
Published: (2020-05-01)

The role of 18F-FDG PET/CT in the management of large-vessel vasculitis: applications and limitations in clinical practice
by: Maria V. Mattoli, et al.
Published: (2012-01-01)

Diagnostic Value of FDG PET/MRI in Females With Pelvic Malignancy—A Systematic Review of the Literature
by: Nghi Co Nguyen, et al.
Published: (2020-09-01)

State of the Art in 2022 PET/CT in Breast Cancer: A Review
by: Jules Zhang-Yin
Published: (2023-01-01)

The significance of positron emission and computerized tomography with fluorodeoxyglucose in the post-therapeutic evaluation of patients with uterine carcinoma
by: Jelić Ivona, et al.
Published: (2019-01-01)

Improved visualization of breast tissue on a dedicated breast PET system through ergonomic redesign of the imaging table
by: Michael K. O’Connor, et al.
Published: (2017-12-01)

Use of 18F‐2‐deoxy‐2‐fluoro‐D‐glucose positron emission tomography/computed tomography for staging thyroid carcinoma in a cat
by: Seonggweon Kang, et al.
Published: (2023-05-01)

An economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
by: P Auguste, et al.
Published: (2011-04-01)

Timing of fluorodeoxyglucose positron emission tomography maximum standardized uptake value for diagnosis of local recurrence of non‐small cell lung cancer after stereotactic body radiation therapy
by: Daren Tan, et al.
Published: (2020-10-01)

Detection of Pacemaker Lead Infection by Fluorodeoxyglucose Positron Emission Tomography
by: Takashi Miura, MD, et al.
Published: (2006-01-01)

Addison’s disease due to bilateral adrenal tuberculosis on 18F-fluorodeoxyglucose positron emission tomography computed tomography
by: Sung Ae Koh
Published: (2018-09-01)

Giant Polyostotic Fibrous Dysplasia: F-18-flourodeoxyglucose Positron Emission Tomography/Computerized Tomography and Radiologic Findings
by: Melis Baykara Ulusan, et al.
Published: (2020-03-01)

Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced Pseudoprogression
by: Sif Homburg, et al.
Published: (2024-02-01)

Role of 18 fluorine-fluorodeoxyglucose positron emission tomography/computed tomography in assessment of neoadjuvant chemotherapy response in breast cancer patients
by: Eslam Abdul Salam Sarhan, et al.
Published: (2020-07-01)

Immunohistophenotyping and 18F-FDG PET-CT in characterizing malignant breast tumors: preliminary results
by: A. Fathinul Fikri, et al.
Published: (2020-03-01)

Utility of 2-Deoxy-2-[18F]fluoro-Dglucose positron emission tomography/computed tomography scan in the systemic evaluation of patients with post-COVID-19 endogenous presumed fungal endophthalmitis
by: Salil Mehta, et al.
Published: (2021-01-01)

Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow‐up fluorine‐18 fluorodeoxyglucose positron emission tomography
by: Daichi Maeda, et al.
Published: (2019-08-01)

Usefulness of fluorodeoxyglucose positron emission tomography/computed tomography for detection of a neuroblastic nodule in a ganglioneuroblastoma: a case report
by: Yuka Takeda, et al.
Published: (2018-05-01)

Comparing the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI for detecting bone metastases in breast cancer: a meta-analysis
by: Xia Longjie, et al.
Published: (2023-07-01)

Characteristics of Smoothing Filters to Achieve the Guideline Recommended Positron Emission Tomography Image without Harmonization
by: Yuji Tsutsui, et al.
Published: (2018-01-01)

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature
by: Leila Allahqoli, et al.
Published: (2023-10-01)

MRI VS. FDG-PET for diagnosis of response to neoadjuvant therapy in patients with locally advanced rectal cancer
by: Peng Fei Gao, et al.
Published: (2023-01-01)

Comparison of MRI vs. [<sup>18</sup>F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives
by: Matteo Caracciolo, et al.
Published: (2023-08-01)

Enhanced Computed Tomography and <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Uncommon Histiocytic Sarcoma of Small Intestine Arising after Gastric Large B-Cell Lymphoma
by: Miju Cheon, et al.
Published: (2023-10-01)

Usefulness of Topically Applied Sensors to Assess the Quality of 18F-FDG Injections and Validation Against Dynamic Positron Emission Tomography (PET) Images
by: Ronald K. Lattanze, et al.
Published: (2018-11-01)

A case report of calcific aterosclerosis demonstrated on 18-F-fluorodeoxyglucose positron emission tomography/computed tomography
by: Antonella Laria, et al.
Published: (2021-10-01)

Role of positron-emission tomography/computed tomography (PET/CT) in breast cancer
by: Mohamed Shawky, et al.
Published: (2020-07-01)

Impact of Renal Failure on F18-FDG PET/CT Scans
by: Vishwajit Kode, et al.
Published: (2017-07-01)

Diagnostic Performance of Dynamic Whole-Body Patlak [<sup>18</sup>F]FDG-PET/CT in Patients with Indeterminate Lung Lesions and Lymph Nodes
by: Matthias Weissinger, et al.
Published: (2023-06-01)

18F-fluorodeoxyglucose–positron emission tomography/computed tomography for the diagnosis of polymyalgia-like illnesses: a retrospective study
by: Hideyuki Horikoshi, et al.
Published: (2020-04-01)

Oncology and cardiology positron emission tomography/computed tomography faced with COVID-19: A review of available literature data
by: Ryogo Minamimoto
Published: (2022-10-01)

Imaging Inflammation with Positron Emission Tomography
by: Janette Iking, et al.
Published: (2021-02-01)

FDG PET/CT and MR imaging of intramuscular myxoma in the gluteus maximus
by: Nishio Jun, et al.
Published: (2012-06-01)